Chondrosarcoma is a malignant (cancerous) tumor, typically found in the cartilage cells of the femur, arm, pelvis, knee, and spine. Rarely, this cancer may affect the ribs and other areas.
Chondrosarcoma also can originate at the skull base from the cartilage between the clivus and the petrous bone. This is called petro-clival synchondrosis.
As with all cancers, the prognosis or outcome depends upon how large the tumor is and whether it has spread to distant structures.
Chondrosarcoma most often occurs in people between 50 and 70 years old. It rarely affects people younger than 20. Males and females are at equal risk of developing chondrosarcoma.
Symptoms can include a large lump or mass on a bone, pressure surrounding the mass, or severe pain. Symptoms of chondrosarcoma of the skull base are neurological, and may include headaches, as well as vision or hearing disturbances.
At UPMC, the preferred surgical treatment for chondrosarcoma of the skull base is the Endoscopic Endonasal Approach (EEA). This innovative, minimally invasive technique uses the nose and nasal cavities as natural corridors to access hard-to-reach or previously inoperable tumors. Benefits of EEA include:
To make the diagnosis of chondrosarcoma, your doctor will ask you about your symptoms and medical history and perform a physical exam.
Symptoms of chondrosarcoma of the skull base (petro-clival synchondrosis) may include:
Diagnostic tests may include:
Treatment options for chondrosarcomas vary based on the patient, but surgery is most common.
Surgery is the main treatment used to remove and treat chondrosarcomas of the skull base, or petro-clival synchondrosis.
Chondrosarcomas of the skull base may be approached directly using the Endoscopic Endonasal Approach (EEA).This state-of-the-art, minimally invasive treatment approach allows surgeons to access the tumor through the natural corridor of the nose, without making an open incision. Surgeons then remove the chondrosarcoma through the nose and nasal cavities.
EEA offers the benefits of no incisions to heal, no disfigurement, and a faster recovery time.
If you need complementary treatments, such as radiation, those therapies can begin soon after EEA surgery.
Additional treatments for chondrosarcoma may include chemotherapy or radiation therapy.
How can we help you?
Schedule anappointment >
Ask a question >
Request our expertopinion >
1-877-986-9862(within the U.S.)
Affiliated with the University of Pittsburgh Schools of the Health Sciences
| Supplemental content provided by Healthwise, Incorporated. To learn more, visit www.healthwise.org
For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.
UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, gender identity, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.
Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.
Pittsburgh, PA, USA | UPMC.com